Skip to main content

Treating Infectious Diseases in a Microbial World Report of Two Workshops on Novel Antimicrobial Therapeutics (2006) / Chapter Skim
Currently Skimming:

Appendix B New Classes of Antimicrobials Committee Biographical Sketches
Pages 65-68

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 65...
... , and been involved in scientific advisory capacity for Genzyme, Immunogen, Leukosite, Kosan Biosciences, Millennium, Versicor, Transform Pharmaceuticals, Critical Therapeutics, and MPM capital. He sits on the Board of Directors of Critical Therapeutics, Kosan, Microbia, and Vicuron.
Read the entire page →
From page 66...
... Program and served as Senior Associate Dean for Research and Acting Dean of Cornell University Medical College. He previously was on the faculty at the Rockefeller University.
Read the entire page →
From page 67...
... APPENDIX B 67 of Medicine at Harvard Medical School. Following graduation from Harvard Medical School, Dr.
Read the entire page →
From page 68...
... For the last thirty years he has worked in pharmaceutical research, specializing in infectious diseases and natural products-based drug discovery. His research was carried out at Glaxo, Lederle and Bristol Myers Squibb in positions of increasing responsibility.
Read the entire page →

Key Terms

  • critical therapeutics
  • infectious disease
  • medical college
  • university medical


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.